The challenges of ‘medical cannabis’ and mental health: a clinical perspective | Zendy

NewtonHowes Giles | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The challenges of ‘medical cannabis’ and mental health: a clinical perspective

Author(s) -

NewtonHowes Giles

Publication year - 2018

Publication title -

british journal of clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.216

H-Index - 146

eISSN - 1365-2125

pISSN - 0306-5251

DOI - 10.1111/bcp.13687

Subject(s) - cannabis , medical cannabis , medical prescription , psychiatry , cannabinoid , perspective (graphical) , medicine , mental health , effects of cannabis , pharmacopoeia , alternative medicine , pharmacology , cannabidiol , receptor , pathology , artificial intelligence , computer science

The use of cannabis as a medicine has a long tradition in Western medicine. It has been seen as a viable option for the treatment of various neurological and psychiatric conditions, and recently there is again interest in the place of cannabinoids in the pharmacopoeia. What has become increasingly clear, however, is these benefits need to be weighed carefully against the potential difficulty associated with herbal cannabis and cannabinoid compounds for an individual's mental health. This challenges the use of cannabis as a medication and the regulation of its prescription.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research